GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis

per Moore, L.E., Baris, D.R., Figueroa, J.D., Garcia-Closas, M., Karagas, M.R., Schwenn, M.R., Johnson, A.T., Lubin, J.H., Hein, D.W., Dagnall, C.L., Colt, J.S., Kida, M., Jones, M.A., Schned, A.R., Cherala, S.S., Chanock, S.J., Cantor, K.P., Silverman, D.T., Rothman, N.
Publicat 2011